← Open Payments lookup

WILLIAM KORNEGAY: Open Payments

NPI 1366160277 · NEW LONDON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,032 in 131 payments from 13 companies in 2025. Trend: 2023 $1,844 · 2024 $1,877 · 2025 $3,032

Food & beverage: $3,008Education: $24
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.28$649
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$533
Neurocrine BioSciences, Inc.16$352
ABBVIE INC.18$256
Alkermes, Inc.11$249
Janssen Pharmaceuticals, Inc7$229
Otsuka America Pharmaceutical, Inc.7$208
Vanda Pharmaceuticals Inc.9$170
Lundbeck LLC6$158
Teva Pharmaceuticals USA, Inc.5$105

Products named: COBENFY, CAPLYTA, INGREZZA, VRAYLAR, REXULTI, INVEGA SUSTENNA, FANAPT, ARISTADA.

Industry payments across CT — which companies pay providers there.